Insider Transactions Reported by 20 Insiders of TherapeuticsMD, Inc.

Symbol
TXMD on Nasdaq
Location
Boca Raton, FL

Insiders trading volume in the past year

TherapeuticsMD, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert G. Finizio CEO, Director $50,067,163 01 Jul 2021
John C.K. Milligan IV Secretary/CEO of subsidiary $12,698,322 10 May 2021
Hugh O'Dowd Chief Executive Officer $11,415,713 31 Mar 2022
Rubric Capital Management LP Director, Other*, 10%+ Owner $10,620,107 15 Nov 2023
James DArecca Chief Financial Officer $2,458,523 10 Aug 2021
Edward Borkowski EVP, Operations $1,459,128 01 Jul 2021
Mark A. Glickman Co-Chief Executive Officer $466,347 06 Dec 2022
J. MARTIN CARROLL Director $239,268 10 Aug 2021
Michael C. Donegan Prin. Fin. and Acctg. Officer $138,489 12 Apr 2023
Cooper C. Collins Director $104,935 03 Nov 2025
Marlan D. Walker Chief Executive Officer $76,534 +$2,483 +3.4% 03 Nov 2025
Tommy G. Thompson Director $62,794 +$14,356 +30% 23 Dec 2025
Brian Bernick Co-Chief Executive Officer $47,065 06 Dec 2022
Paul Bisaro Director $31,450 29 Sep 2022
Angus C. Russell Director $31,159 29 Sep 2022
Karen Ling Director $28,470 29 Sep 2022
Jules A. Musing Director $27,196 29 Sep 2022
Joseph Ziegler Principal Financial Officer $16,793 17 Aug 2023
Ph.D. Gail K. Naughton Director $14,739 03 Nov 2025
Justin Hunter Roberts Director 23 Aug 2022

Recent Insider Transactions by Companies or Individuals for TherapeuticsMD, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.